Mills EL, Pierce KA, Jedrychowski MP, Garrity R, Winther S, Vidoni S, et al
10.1155/2015/470219 25 GuP.JinX.LiX.WuY
Biochemistry 64 (5), 11211135
John Rush has received consulting fees from Compass Inc., Curbstone Consultant LLC, Emmes Corp., Evecxia Therapeutics, Inc., Holmusk Technologies, Inc., ICON, PLC, Johnson and Johnson (Janssen), Liva-Nova, MindStreet, Inc., Neurocrine Biosciences Inc., Otsuka-US
Without-DAC protocols dose both compounds together multiple times daily to match the short CJC-1295 half-life
doi: 10.1021/acs.molpharmaceut.0c00138 77 LiSYuanSZhaoQWangBWangXLiK